There is currently no cure for ovarian cancer, neither is there an early detection test, due to limited funding for research. It's a cancer doctors and society know little, and talk even less, about. Brother and sister duo Camilla and Marc know this well, having lost their mother to ovarian cancer when they were 11 and 13 years old. Today, the siblings behind the Australian luxury fashion brand CAMILLA AND MARC are using their platform to fund pioneering new research and re-shape the narrative around ovarian cancer with the campaign Ovaries: Talk About Them.
Since Camilla and Marc's mother passed away almost 30 years ago, very little has advanced or changed around ovarian cancer, the deadliest female cancer. Over 300,000 women are diagnosed every year worldwide, yet 75% are diagnosed when it is too late for effective treatment. Having launched their label over twenty years ago, Camilla and Marc are using their international platform as a global luxury fashion brand to raise awareness of ovarian cancer. Founding an annual campaign in 2020, their goal by 2026 is to have the world's first early-detection blood test for ovarian cancer approved by clinical trials and in circulation at local GPs.
For this year's campaign, the Sydney-based brand have partnered with London-based artist Alba Hodsoll to create a limited-edition collection of unisex t-shirts and sweaters. Hodsoll, renowned globally for her work of the female form, abstractly illustrates a vagina and ovaries for this year's collection. While the latest edition of Ovaries. Talk About Them launches Tuesday 28 March, with 100% of profits donated directly to the early detection research led by Professor Caroline Ford and her team at the UNSW's Ovarian Cancer Research Centre, the campaign takes donations all year round.
'This is not just another ovarian cancer campaign,' comments creative director Camilla Freeman-Topper. 'It is a movement that exists for all women, globally. The diabolical statistics women with ovarian cancer face have not changed in over 30 years, as gynaecological cancers remain woefully underfunded and under researched - an indictment on the system that we must collectively change. It’s the year 2023 and the time is now to break down the stigma and stand up so that together, we can fund this early detection test for ovarian cancer and change the face of this disease. We all come from ovaries. We all love someone with ovaries. For the sake of our mothers, our sisters, our daughters, our best friends, our aunties and our grandmothers. This is for you.'
Now in its consecutive fourth year, the Ovaries. Talk About Them movement exists, above all else, to chart a dramatic course for change; to fight for a woman’s basic right to healthcare and demands that, quite frankly, women deserve better when it comes to ovarian cancer and gynaecological disease in general. By 2040, the number of women around the world diagnosed with ovarian cancer will rise by almost 42% and the number of women dying from ovarian cancer each year will increase by 50%. The time is now for global policy-makers and governments to recognise the devastating impact of ovarian cancer on women, families, societies and economies. CAMILLA AND MARC's campaign must only be the beginning.